RT Journal Article SR Electronic T1 Pulmonary hypertension in patients with chronic myeloproliferative disorders JF European Respiratory Review JO EUROPEAN RESPIRATORY REVIEW FD European Respiratory Society SP 400 OP 410 DO 10.1183/16000617.0041-2015 VO 24 IS 137 A1 Yochai Adir A1 Davide Elia A1 Sergio Harari YR 2015 UL http://err.ersjournals.com/content/24/137/400.abstract AB Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD's: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.Epidemiology, pathogenic mechanism and treatment approach of PH in patients with chronic myeloproliferative diseases http://ow.ly/Q1QX4